13.10.2022 15:42:00

EQS-DD: BRAIN Biotech AG english




Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

13.10.2022 / 15:40 CET/CEST
The issuer is solely responsible for the content of this announcement.








1. Details of the person discharging managerial responsibilities / person closely associated

a) Name




Title: Dr.
First name: Georg
Last name(s): Kellinghusen

2. Reason for the notification

a) Position / status




Position: Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
BRAIN Biotech AG

b) LEI
391200JKPVHLD6JLZ107 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code




Type: Share
ISIN: DE0005203947

b) Nature of the transaction


Acquisition

c) Price(s) and volume(s)






Price(s) Volume(s)
4.88 EUR 4587.20 EUR
4.96 EUR 297.60 EUR

d) Aggregated information




Price Aggregated volume
4.8848 EUR 4884.80 EUR

e) Date of the transaction
12/10/2022; UTC+2

f) Place of the transaction




Name: Xetra
MIC: XETR



13.10.2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
















Language: English
Company: BRAIN Biotech AG
Darmstädter Straße 34-36
64673 Zwingenberg
Germany
Internet: www.brain-biotech.com



 
End of News EQS News Service





78861  13.10.2022 CET/CEST



fncls.ssp?fn=show_t_gif&application_id=1463463&application_name=news&site_id=smarthouse

Analysen zu BRAIN Biotech AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

BRAIN Biotech AG 3,25 2,20% BRAIN Biotech AG